GlassScriptPhysician profile
James S Linder
NPI 1578640660
$17,781.51
in general payments reported to CMS, 2019-2025
20 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $4,309 · 2021: $6,500 · 2022: $5,659 · 2023: $242 · 2024: $376 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $142.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $13,862.93 | 2019-2023 | Tepezza |
| Merz North America, INC. | $1,791.15 | 2019-2023 | |
| Katena Products, INC. (Dba Corza Medical) | $1,002.50 | 2019-2022 | |
| Amgen INC. | $370.58 | 2024-2025 | Tepezza |
| Revance Therapeutics, INC. | $147.52 | 2025 | Daxxify |
| Abbvie INC. | $142.00 | 2024-2025 | |
| Genentech USA, INC. | $104.19 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $87.16 | 2022-2023 | Seglentis |
| Biotissue Holdings INC. | $36.47 | 2025 | |
| Eyevance Pharmaceuticals LLC | $35.88 | 2019-2022 | |
| Allergan, INC. | $34.50 | 2022 | |
| Depuy Synthes Sales INC. | $25.28 | 2023 | Na |
| Novartis Pharmaceuticals Corporation | $22.92 | 2022 | |
| Organogenesis INC. | $22.33 | 2025 | Novachor |
| Teleflex LLC | $19.81 | 2024 | Urolift |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $18.02 | 2025 | Purified Cortrophin Gel |
| Avanos Medical | $17.68 | 2022 | |
| Heron Therapeutics, INC. | $15.13 | 2022 | |
| Ucb, INC. | $13.84 | 2025 | Rystiggo |
| Kala Pharmaceuticals, INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Linder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.